RNA-seq and miRNA-seq data from pharmacological inhibition of the G9a/GLP histone methyltransferase complex with UNC0642

Published: 3 December 2020| Version 3 | DOI: 10.17632/f47bm47bcw.3
Shrikant Pawar


Growing evidence demonstrates the epigenetic modulation as a key event in Alzheimer’s disease (AD) pathology. Furthermore, recent data suggests that the epigenetic regulation by the methyltransferase G9a is a crucial mechanism involved in learning and memory formation. Taking this into account, the present study provides genomics data from pharmacological intervention with UNC0642, a potent and selective G9a/GLP in SAMP8 mice, a model of Alzheimer’s disease (AD). We have generated novel RNA-seq and miRNA-seq data for three groups, healthy SAMR1, SAMP8 control and SAMP8 treated with UNC0642 (5mg/Kg). Thus, the new data can be used to find miRNA regulation, and the mRNA’s modified in AD under G9a/GLP inhibition.



Universitat de Barcelona - Campus Mundet


Life Sciences